Kamada Ltd. (TLV:KMDA)
Israel · Delayed Price · Currency is ILS · Price in ILA | Market Cap | 1.31B -4.3% |
| Revenue (ttm) | 573.62M +8.6% |
| Net Income | 64.30M +26.8% |
| EPS | 1.10 +24.4% |
| Shares Out | 57.69M |
| PE Ratio | 20.63 |
| Forward PE | 16.60 |
| Dividend | 0.73 (3.21%) |
| Ex-Dividend Date | Mar 23, 2026 |
| Volume | 11,319 |
| Average Volume | 66,951 |
| Open | 2,275.00 |
| Previous Close | 2,275.00 |
| Day's Range | 2,230.00 - 2,281.00 |
| 52-Week Range | 1,956.00 - 2,890.00 |
| Beta | 0.20 |
| RSI | 38.33 |
| Earnings Date | May 13, 2026 |
About Kamada
Kamada Ltd. provides plasma-derived protein therapeutics. It operates in two segments, Proprietary Products and Distribution. The company offers KAMRAB/KEDRAB for prophylaxis of rabies disease; CYTOGAM for prophylaxis of cytomegalovirus disease in kidney, lung, liver, pancreas, heart, and heart/lung transplant; WINRHO SDF for immune thrombocytopenic purpura and suppression of rhesus isoimmunization; HEPAGAM B for prevention of hepatitis B recurrence liver transplants and post-exposure prophylaxis; VARIZIG for post exposure prophylaxis of varice... [Read more]
Full Company ProfileFinancial Performance
In 2025, Kamada's revenue was $180.46 million, an increase of 12.12% compared to the previous year's $160.95 million. Earnings were $20.20 million, an increase of 39.66%.
Financial numbers in USD Financial StatementsNews
Kamada (KMDA) Maintains 2026 Financial Projections
Kamada (KMDA) Maintains 2026 Financial Projections
Kamada (KMDA) Reports Strong Q1 Revenue Growth
Kamada (KMDA) Reports Strong Q1 Revenue Growth
Kamada Releases Q1 2026 Financial Results
Kamada Ltd. The post Kamada Releases Q1 2026 Financial Results first appeared on Alphastreet .
Kamada Earnings Call Transcript: Q1 2026
Q1 2026 results were solid, with revenues of $42.5 million and adjusted EBITDA of $11.6 million, despite a temporary shipment delay. 2026 guidance is reaffirmed, with strong demand across key products and ongoing expansion in biosimilars and plasma collection.
Kamada reports Q1 EPS 7c, consensus 12c
Reports Q1 revenue $45.24M vs. $44.02M last year. “Our operational and financial performance in 2026 is off to a solid start, with first quarter revenues and adjusted EBITDA in line…
Kamada backs FY26 revenue view $200M-$205M
backs Fy26 adjusted EBITDA view $50M-$53M. The company said, “Kamada (KMDA) is reiterating its 2026 annual financial guidance of total revenues in the range of $200 million to $205 million…
Kamada Reports First Quarter 2026 Financial Results and Affirms 2026 Annual Guidance; Expecting Significantly Stronger Remainder of the Year
Q1-2026 Revenue of $45.2 Million, up 3% Year-over-Year; Adjusted EBITDA of $11.6 Million, representing a Robust 26% Margin of Revenues ; Net Income of $4.1 Million, up 4% Year-over-Year Underlying Dem...
Stay Ahead of the Game With Kamada (KMDA) Q1 Earnings: Wall Street's Insights on Key Metrics
Get a deeper insight into the potential performance of Kamada (KMDA) for the quarter ended March 2026 by going beyond Wall Street's top-and-bottom-line estimates and examining the estimates for some o...
Kamada to Announce First Quarter 2026 Financial Results on May 13, 2026
REHOVOT, Israel and HOBOKEN, N.J., May 06, 2026 (GLOBE NEWSWIRE) -- Kamada Ltd.
Significant Move: Lilach Payorski Invests $80K In Kamada Stock Options
Disclosed in a recent SEC filing, Lilach Payorski , Board Member at Kamada (NASDAQ: KMDA), made a strategic move by acquiring company stock options on April 9,. What Happened: Uncovered in a Form 4 f...
Eran Nir Sees Potential Growth And Acquires $178K In Kamada Stock Options
A noteworthy insider acquisition was disclosed on April 9, as Nir, VP at Kamada (NASDAQ: KMDA), reported the acquisition of stock options for 112,500 shares. What Happened: Nir, VP at Kamada, engaged...
David Tsur Takes A Bullish Stance, Acquiring $113K Worth Of Kamada Stock Options
A substantial insider move unfolded on April 9, as Tsur, Director at Kamada (NASDAQ: KMDA), reported the acquisition of stock options for 56,500 shares in an SEC filing. What Happened: Disclosed in a...
Ishay Davidi Expands Holdings With $113K Kamada Stock Options Acquisition
Ishay Davidi , Board Member at Kamada (NASDAQ: KMDA), reported acquisition of company stock options on April 9, according to a new SEC filing. What Happened: In a recent Form 4 filing with the U.S. S...
Chaime Orlev At Kamada Secures Company Stock Options: $417K Acquired
A substantial insider move unfolded on April 9, as Orlev, Chief Financial Officer at Kamada (NASDAQ: KMDA), reported the acquisition of stock options for 202,500 shares in an SEC filing. What Happene...
Nir Livneh Enhances Portfolio With Kamada Stock Options: $206K Acquired
In a new SEC filing on April 9, it was unveiled that Livneh, VP at Kamada (NASDAQ: KMDA), acquired stock options for 99,485 shares. What Happened: Livneh, VP at Kamada, engaged in a derivative transa...
Benjamin Dekel Takes A Bullish Stance, Acquiring Kamada Stock Options Worth $41K
In a recent SEC filing, it was disclosed that Benjamin Dekel, Director at Kamada (NASDAQ: KMDA), made a noteworthy acquisition of company stock options on April 9,. What Happened: Dekel, Director at ...
Leon Recanati Expands Holdings With $115K Kamada Stock Options Acquisition
A notable acquisition unfolded on April 9, as Recanati, Director at Kamada (NASDAQ: KMDA), reported the acquisition of stock options for 56,500 shares in an SEC filing. What Happened: Recanati, Direc...
Assaf Itshayek Sees Potential Growth And Acquires Kamada Stock Options Worth $41K
A noteworthy insider acquisition was disclosed on April 9, as Itshayek, Director at Kamada (NASDAQ: KMDA), reported the acquisition of stock options for 16,000 shares. What Happened: In a recent Form...
Hanni Neheman Backs Up Beliefs With A Notable $118K Acquisition In Kamada Stock Options
A notable acquisition unfolded on April 9, as Neheman, VP at Kamada (NASDAQ: KMDA), reported the acquisition of stock options for 75,000 shares in an SEC filing. What Happened: Disclosed in a Form 4 ...
Kamada (KMDA) Secures Favorable Tax Ruling on Cash Dividend
Kamada (KMDA) Secures Favorable Tax Ruling on Cash Dividend
Kamada updates on withholding tax procedures for cash dividend
Kamada (KMDA) announced that it has obtained a tax ruling from the Israel Tax Authority with respect to the cash dividend of 25c per share on the company’s ordinary shares
Kamada announces FDA approval for plasma collection center in San Antonio
Kamada (KMDA) announced that the FDA has approved Kamada Plasma’s collection center in San Antonio, Texas. The approval was obtained following an on-site inspection made by the FDA during February.
Kamada Announces FDA Approval of its Plasma Collection Center in San Antonio, Texas
REHOVOT, Israel and HOBOKEN, N.J., March 26, 2026 (GLOBE NEWSWIRE) -- Kamada Ltd. (NASDAQ: KMDA; TASE: KMDA.TA), a global biopharmaceutical company with a portfolio of marketed products indicated for ...
Kamada Ltd (KMDA) Q4 2025 Earnings Call Highlights: Strong Revenue Growth and Strategic Outlook
Kamada Ltd (KMDA) Q4 2025 Earnings Call Highlights: Strong Revenue Growth and Strategic Outlook
Q4 2025 Kamada Ltd Earnings Call Transcript
Q4 2025 Kamada Ltd Earnings Call Transcript